Multifunctional Smart Injectable Triblock Copolymer Hydrogel for Highly Efficient Dual Drug−Gene Delivery in Triple-Negative Breast Cancer

Le résumé fourni par la source

Triple-negative breast cancer (TNBC) remains one of the most aggressive breast cancer subtypes, lacking targeted therapies and exhibiting elevated levels of intracellular Cu 2+ ions. Smart multifunctional nanocarriers capable of dual drug−gene delivery offer a promising strategy for improved TNBC management. In this study, we present an injectable, triple-stimuli-responsive polymeric nanocarrier engineered via reversible addition−fragmentation chain-transfer (RAFT) polymerization for targeted TNBC theranostics. The amphiphilic triblock copolymer integrates three functional components: a photochromic spiropyran (SP) unit enabling light responsiveness, a pH-sensitive cationic hydroxyethyl methacrylate−glycine (HEMA-Gly) segment facilitating nucleic acid complexation, and a temperature-responsive N-isopropylacrylamide (NIPAAM) unit enabling thermally triggered behavior. Notably, the nanocarrier shows strong fluorescence quenching in the presence of Cu 2+ ionsoverexpressed in TNBCsupporting selective cellular recognition. Doxorubicin (DOX) loading and release studies demonstrated controlled, sustained release under mildly acidic conditions mimicking the tumor microenvironment. In vitro evaluations using MDA-MB-231 TNBC cells confirmed the platform’s multifunctionality. Cytotoxicity assays indicated biocompatibility, while fluorescence imaging revealed efficient cellular uptake of DOX-loaded micelles. Furthermore, the system modulated cell cycle progression and significantly enhanced intracellular and mitochondrial reactive oxygen species (ROS) production, indicating the potential to induce ROS-mediated apoptosis. Gene delivery experiments showed high transfection efficiency of nucleic acid-loaded micelles, attributed to the cationic HEMA-Gly block. Additionally, intracellular quenching studies confirmed the polymer’s selective sensitivity toward TNBC-associated Cu 2+ ions. Overall, the RAFT-synthesized triblock copolymer represents a versatile theranostic platform capable of simultaneous drug release, gene transfection, ROS induction, and Cu 2+ -guided TNBC detection. Its targeted responsiveness and multifunctional performance highlight its promise for advanced TNBC diagnostics and combination therapy.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.